Innovation Insights: AI in small molecule discovery
Summary
AI and ML technologies are being increasingly used in small molecule discovery, with a surge in patenting activity, particularly from tech and China-based companies. Pharma companies are also entering this space, filing patents on molecules generated by AI-based screening. The innovation landscape is dominated by China-based companies like Ping An, Tencent, and Baidu, with tech companies making up 57% of the total. The startup ecosystem is robust with 45+ startups, 30% of which are based in China. The AI in Small Molecule Drugs landscape is dominated by innovator drugs, with a focus on Oncology and Central Nervous System therapies. Investment activity has been significant, with 768 deals totaling $137.1 billion, the majority of which are from the US.
AI-based small molecule discovery, which uses AI and ML technologies is a high-impact innovation area with increasing citation activity and new entrants. Patenting activity is growing rapidly, dominated by tech and China-based companies. Notably, pharma companies like Takeda Pharma and Lantern Pharma are filing patents, often on molecules generated by AI-based screening. China-based companies like Ping An, Tencent, and Baidu lead the innovation landscape, with 57% of all companies in this space being tech companies. The startup ecosystem consists of 45+ startups, 30% of which are based in China. The AI in Small Molecule Drugs landscape, with 1,220 drugs, is dominated by innovator drugs focusing on Oncology and Central Nervous System therapies. Investment activity in this field has seen 768 deals totaling $137.1 billion, with the US leading in M&A deals.
How is our ‘State of Innovation intelligence 2024’ report unique from other reports in the market?
Our report stands out by integrating diverse, high-value data streams-patents, drugs, clinical trials, and deals-into one comprehensive resource.
This holistic approach provides a panoramic view of the AI-driven small molecule drug screening landscape, allowing you to uncover critical competitive insights, track emerging IP trends, and spot new market opportunities. Unlike many reports that focus on a single aspect, our report delivers actionable intelligence across the entire innovation cycle, from early-stage research to regulatory considerations and market adoption.
This depth and breadth of analysis not only inform strategic decision-making but also empower stakeholders to stay ahead in an increasingly competitive and fast-evolving industry.
We recommend this valuable source of information to anyone involved in -
Drug Development and Pharma/Biotech Companies - Value chain
Pharmaceutical Industry Suppliers and Distributors
Pharma/Drug Manufacturing Companies - Leaders and Startups
Business Development and Market Intelligence
Investment Analysts and Portfolio Managers
Professional Services - Investment Banks, PE/VC Firms
M&A/Investment, Management Consultants, and Consulting Firms
Key Highlights
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook